These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38839111)

  • 1. Modulation of Angiotensin II-Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites.
    Alammari AH; Isse FA; O'Croinin C; Davies NM; El-Kadi AOS
    Drug Metab Dispos; 2024 Jul; 52(8):875-885. PubMed ID: 38839111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
    Shoieb SM; El-Kadi AOS
    Mol Cell Biochem; 2020 Aug; 471(1-2):165-176. PubMed ID: 32533462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro.
    Alammari AH; Gerges SH; Isse FA; El-Kadi AOS
    Drug Metab Dispos; 2023 Jul; 51(7):833-843. PubMed ID: 37185150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
    Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
    Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Shoieb SM; El-Kadi AOS
    Drug Metab Dispos; 2018 Aug; 46(8):1157-1168. PubMed ID: 29880629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
    Elkhatali S; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; El-Kadi AO
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):550-9. PubMed ID: 26454030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
    Alammari AH; Shoieb SM; Maayah ZH; El-Kadi AOS
    J Pharm Sci; 2020 Jul; 109(7):2321-2335. PubMed ID: 32240690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners.
    Isse FA; Alammari AH; El-Sherbeni AA; El-Kadi AOS
    Prostaglandins Other Lipid Mediat; 2023 Oct; 168():106749. PubMed ID: 37244564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy.
    Elkhatali S; Maayah ZH; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; Shoieb SM; El-Kadi AOS
    J Cardiovasc Pharmacol; 2017 Jul; 70(1):16-24. PubMed ID: 28437282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-κB-dependent mechanism.
    Maayah ZH; El-Kadi AO
    Arch Toxicol; 2016 Feb; 90(2):359-73. PubMed ID: 25600587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 1B1 is critical in the development of TNF-α, IL-6, and LPS-induced cellular hypertrophy.
    ElKhatib MAW; Gerges SH; Isse FA; El-Kadi AOS
    Can J Physiol Pharmacol; 2024 Jul; 102(7):408-421. PubMed ID: 38701513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism.
    Hidayat R; Shoieb SM; Mosa FES; Barakat K; Brocks DR; Isse FA; Gerges SH; El-Kadi AOS
    Mol Cell Biochem; 2024 Jun; 479(6):1379-1390. PubMed ID: 37436655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1.
    Shoieb SM; Dakarapu R; Falck JR; El-Kadi AOS
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):613-624. PubMed ID: 34235626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats.
    Aboutabl ME; Zordoky BN; El-Kadi AO
    Br J Pharmacol; 2009 Dec; 158(7):1808-19. PubMed ID: 19889059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy.
    El-Sherbeni AA; El-Kadi AO
    Biochem Pharmacol; 2014 Feb; 87(3):456-66. PubMed ID: 24300133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol.
    Althurwi HN; Maayah ZH; Elshenawy OH; El-Kadi AO
    Drug Metab Dispos; 2015 Aug; 43(8):1254-66. PubMed ID: 26033621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
    Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.
    Zordoky BN; Aboutabl ME; El-Kadi AO
    Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 19-(
    Shoieb SM; El-Sherbeni AA; El-Kadi AOS
    Drug Metab Dispos; 2019 Feb; 47(2):67-70. PubMed ID: 30420405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
    Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.